Paul Slowey
Vorstandsvorsitzender bei Oasis Diagnostics Corp.
Profil
Paul D.
Slowey is currently the Chief Executive Officer at Oasis Diagnostics Corp.
since 2007 and the Managing Member at Bamburgh Marrsh LLC since 2002.
He was previously the President & Director at BioCurex, Inc. Dr. Slowey holds a doctorate degree from Newcastle University and an undergraduate degree from Sheffield College.
Aktive Positionen von Paul Slowey
| Unternehmen | Position | Beginn |
|---|---|---|
Oasis Diagnostics Corp.
 Oasis Diagnostics Corp. Medical SpecialtiesHealth Technology Oasis Diagnostics Corp. develops collection tools, diagnostic and testing devices. The private company is based in Vancouver, WA. Paul D. Slowey has been the CEO of the company since 2007. | Vorstandsvorsitzender | 01.01.2007 |
Bamburgh Marrsh LLC
 Bamburgh Marrsh LLC Medical SpecialtiesHealth Technology Part of MDM Group, Inc., Bamburgh Marrsh LLC is a company that manufactures test kits for the detection of diseases. The company is based in Vancouver, WA. Bamburgh Marrsh was acquired by MDM Group, Inc. on May 09, 2005 for $4 million. | Corporate Officer/Principal | 01.01.2002 |
Ehemalige bekannte Positionen von Paul Slowey
| Unternehmen | Position | Ende |
|---|---|---|
| BIOCUREX INC | Präsident | - |
Ausbildung von Paul Slowey
| Newcastle University | Doctorate Degree |
| Sheffield College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
BioCurex, Inc.
 BioCurex, Inc. BiotechnologyHealth Technology BioCurex, Inc. engages in the business of developing, producing, marketing and licensing products based on patented and proprietary technology in the area of cancer diagnostics. It focuses on developing and commercializing products for the early detection, diagnosis, and monitoring the recurrence of cancer. It has developed a blood test that can detect the presence of cancer in humans and animals using a new cancer marker named RECAF. RECAF is a molecule found on most cancer cells, including breast, colon, prostate and lung cancers, but not on normal cells and it also can be used in blood tests to determine if a patient has cancer. The company was founded by Ricardo Moro-Vidal on December 8, 1997 and is headquartered in Richmond, Canada. | Health Technology |
Bamburgh Marrsh LLC
Bamburgh Marrsh LLC Medical SpecialtiesHealth Technology Part of MDM Group, Inc., Bamburgh Marrsh LLC is a company that manufactures test kits for the detection of diseases. The company is based in Vancouver, WA. Bamburgh Marrsh was acquired by MDM Group, Inc. on May 09, 2005 for $4 million. | Health Technology |
Oasis Diagnostics Corp.
Oasis Diagnostics Corp. Medical SpecialtiesHealth Technology Oasis Diagnostics Corp. develops collection tools, diagnostic and testing devices. The private company is based in Vancouver, WA. Paul D. Slowey has been the CEO of the company since 2007. | Health Technology |